Related Experiment Video
Updated: May 10, 2025

Systematic Hearing Performance Evaluation Process for Adolescents with Cochlear Implantation at Early Ages
Published on: March 24, 2023
Use of Meludia to evaluate the effect of music training in cochlear implant users: study protocol of a randomised
Miryam Calvino1,2,3, Javier Gavilán4,2, Luis Lassaletta4,2,3
1Department of Otorhinolaryngology, La Paz University Hospital, Madrid, Spain miryamcf@yahoo.com.
Introduction:
Although most cochlear implant (CI) users achieve good speech understanding in quiet without visual cues, they may have limited speech understanding in noise and often have poor music perception. The present study was designed to investigate the degree to which the use of Meludia training can improve music perception, music enjoyment and speech understanding in paediatric and postlingually deafened adult CI users. The study also aims to assess the participants' changes in cognitive skills (attention and memory) and quality of life.
Methods And Analysis:
This randomised controlled trial will randomise new CI users and experienced CI users older than 6 years who meet the inclusion criteria in a 1:1 ratio to either a musical training (MT) group or a non-MT (NMT) group. The NMT group will receive standard care that does not include MT. Participants in the MT group will practise with Meludia software for 4 weeks and later for 12 additional weeks. Outcomes will include scores in: 'Listening Up' exercises, the -Music-Related Quality of Life questionnaire, the Music Questionnaire for Paediatric Population, Disyllables in silence, Matrix test, Mini Mental State Examination, Performance IQ and the Wechsler intelligence scale for children and the Assessment of Quality of Life-8 Dimensions questionnaire. The NMT group will receive standard care that does not include MT.
Ethics And Dissemination:
On 16 October 2023, the study protocol was approved by the La Paz Hospital in Madrid (Spain). The findings of this study will be published in peer-reviewed publications and presented at appropriate conferences.
Trial Registration Number:
NCT06540677.

